Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...
11hon MSN
Innate Pharma SA (IPHA) announced that the FDA has granted Breakthrough Therapy Designation to lacutamab for treating adults ...
It’s official, folks! The OnePlus Watch 3 is available for pre-order. Continuing the momentum it established from the OnePlus ...
The OnePlus Watch 3 adds hardware support for ECG, but it wasn't approved for users in the United States or Canada.
Co., Ltd. (hereafter "NX Taiwan"), a group company of NIPPON EXPRESS HOLDINGS, INC., obtained certification on Wednesday, December 18, 2024 from the Taiwan Food and Drug Administration (TFDA) for the ...
The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...
AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...
VCS’s innovative and custom-tailored testing services offer specialized cosmetic clinical testing while helping to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback